Guardant Health
GH
#2456
Rank
NZ$10.55 B
Marketcap
$85.46
Share price
-3.42%
Change (1 day)
135.42%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company